COMMUNIQUÉS West-GlobeNewswire

Positioning ChemoMetec for future growth
10/09/2026
ANNOUNCEMENT NO. 313 10 September 2026 Annual Report 2025/26 (1 July 2025 - 30 June 2026) Positioning ChemoMetec for future growth Despite changes and uncertainty affecting ChemoMetec's markets, revenue grew by 3% to [...]
LifeLabs Celebrates 11 Family Scholarship Recipients for 2026
10/09/2026
Toronto, Canada, Sept. 10, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of laboratory diagnostic information and digital health connectivity systems, is proud to announce the outstanding recipients of [...]
Tecan to participate in upcoming Investor Conference
10/09/2026
Männedorf, Switzerland, September 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will participate in the following investor conference next week: 24 th Annual Morgan Stanley Healthcare [...]
Rad Source Technologies Introduces Sterile Insect Farms™
10/09/2026
Now offering Sterile Mosquitoes for Non-Chemical & Non-GMO Vector Control BUFORD, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, a leading innovator in X-ray solutions for life sciences, is proud [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
10/09/2026
Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: [...]
Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026
10/09/2026
Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from [...]
GENFIT annonce sa participation à la H.C. Wainwright 28th Annual Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, États-Unis), le 10 septembre 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie [...]
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, United States), September 10, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026
10/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
10/09/2026
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
10/09/2026
Healthy volunteer study will evaluate ingestible delivery capsule for oral, needle-free administration of adalimumab with topline data expected by early 2027 SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Biora [...]
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune [...]
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NORCROSS, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that company management will present and [...]
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
10/09/2026
SHENZHEN, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- On September 9, BGI Group held its 2026 Global New Product Launch Event at BGI Center in Shenzhen, marking the organization’s 27th anniversary. Under the theme “ [...]
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
10/09/2026
Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform- [...]
ORYZON to Participate in Upcoming Events in September and October
10/09/2026
MADRID and CAMBRIDGE, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its [...]
Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
10/09/2026
Accomplished biopharmaceutical finance executive brings extensive experience driving capital markets activities, strategic transactions, and growth across public companies JERSEY CITY, N.J., Sept. 10, 2026 (GLOBE [...]
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
DOYLESTOWN, Pa., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of [...]

Pages